BC Platforms cooperating with Australian tissue bank
Zurich - BC Platforms has agreed a partnership with the Australian Breast Cancer Tissue Bank. The company will integrate data from the tissue bank in its digital platform. The partners are aiming to improve breast cancer treatment with this collaboration.
PolyPeptide seeking to launch IPO in Switzerland
Zug/Zurich – The PolyPeptide Group from Sweden is planning an IPO on the SIX Swiss Exchange. The company manufactures peptides that are primarily used in the pharmaceutical and biotechnology industries. CEO Jane Salik regards Switzerland as one of the world’s most attractive locations for the life sciences sector.
Sensirion sensors help in logistics
Stäfa ZH – The US firm Tive develops trackers to monitor transportation conditions for sensitive goods. Its latest innovation features the use of a humidity and temperature sensor developed by the ETH spin-off Sensirion.
Targeted playtime boosts fight against dementia
Zurich/Schindellegi SZ - Cognitive motor training increases attention span, concentration, memory and orientation in people suffering from dementia. These findings are the result of work conducted by a research group that included members from ETH Zurich and its spin-off Dividat.
Skribble enables digital signing in Zug
Zurich/Zug – Residents of Zug are now able to request documents from the town via the eZug app and receive them directly on their cell phones. Legally valid electronic contract signatures are also possible with this. This is based on technology from the electronic signature provider Skribble.
Investors give QUMEA 1.8 million Swiss francs
Solothurn - QUMEA has received start-up financing amounting to 1.8 million Swiss francs from investors. The start-up’s AI sensor technology enables improved service for persons requiring care. A three-dimensional radar detects their position, posture and condition.
Test phase 2 for COVID 19 drugs
Schlieren ZH – The drug candidate ensovibep developed by Molecular Partners has been administered to a first patient with symptomatic COVID-19 disease in a clinical Phase 2 trial. Authorization might still be achieved in 2021.
Futurae raises investment of 5 million francs
Zurich – Futurae Technologies AG has received additional capital of 5 million Swiss francs from new and existing investors. The customer authentication specialist will use this to extend its B2B platform and accelerate international expansion.
Zurich is one of the top start-up hubs
Trento – In 2020, Zurich became more attractive to start-up founders. As recently revealed by the Startup Heatmap Europe Report, which ranks the most popular start-up locations in Europe, Zurich has jumped six places to take 8th position.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space